References
- Li, T.; Ao, E. C. I.; Lambert, B.; Brans, B.; Vandenberghe, S.; Mok, G. S. P. Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review. Theranostics. 2017, 7(18), 4551–4565. DOI: https://doi.org/10.7150/thno.19782.
- Jurcic, J. G.; Wong, J. Y. C.; Knox, S. J.; Wahl, D. R.; Rosenblat, T. L.; Meredith, R. F. Selective. In Targeted Radionuclide Therapy, 4thed; Elsevier Inc, 2016. DOI:https://doi.org/10.3390/cancers3043838.
- Lee, S.; Xie, J.; Chen, X. Peptide-Based Probes for Targeted Molecular Imaging. Biochemistry. 2010, 49(7), 1364–1376. DOI: https://doi.org/10.1021/bi901135x.
- Dankbaar, J. W.; Snijders, T. J.; Robe, P. A.; Seute, T.; Eppinga, W.; Hendrikse, J.; Keizer, B. The Use of 18 F-FDG PET to Differentiate Progressive Disease from Treatment Induced Necrosis in High Grade Glioma. J. Neurooncol. 2015, 125(1), 167–175. DOI: https://doi.org/10.1007/s11060-015-1883-1.
- Nabi, H. A.; Zubeldia, J. M. Clinical Applications of 18F-FDG in Oncology. J. Nucl. Med. Technol. 2002, 30(1), 3–9.
- Van Dongen, G. A. M. S.; Vosjan, M. J. W. D. Immuno-Positron Emission Tomography: Shedding Light on Clinical Antibody Therapy. Cancer Biother. Radiopharm. 2010, 25(4), 375–385. DOI: https://doi.org/10.1089/cbr.2010.0812.
- Boerman, O. C.; Oyen, W. J. G. Immuno-PET of Cancer: A Revival of Antibody Imaging. J. Nucl. Med. 2011, 52(8), 1171–1172. DOI: https://doi.org/10.2967/jnumed.111.089771.
- Alibakhshi, A.; Abarghooi, F.; Ahangarzadeh, S.; Yaghoobi, H.; Yarian, F.; Arezumand, R.; Ranjbari, J.; Mokhtarzadeh, A.; de la Guardia, M. Targeted Cancer Therapy through Antibody Fragments-Decorated Nanomedicines. J. Control. Release. 2017, 268, 323–334. DOI: https://doi.org/10.1016/j.jconrel.2017.10.036.
- Zangemeister-Wittke, U.;. Antibodies for Targeted Cancer Therapy – Technical Aspects and Clinical Perspectives. Pathobiology. 2005, 72, 279–286. DOI: https://doi.org/10.1159/000091325.
- Tavaré, R.; McCracken, M. N.; Zettlitz, K. A.; Knowles, S. M.; Salazar, F. B.; Olafsen, T.; Witte, O. N.; Wu, A. M. Engineered Antibody Fragments for Immuno-PET Imaging of Endogenous CD8+ T Cells in Vivo. Proc. Natl. Acad. Sci. U.S.A. 2014, 111(3), 1108–1113. DOI: https://doi.org/10.1073/pnas.1316922111.
- Vaneycken, I.; D’huyvetter, M.; Hernot, S.; de Vos, J.; Xavier, C.; Devoogdt, N.; Caveliers, V.; Lahoutte, T. Immuno-Imaging Using Nanobodies. Curr. Opin. Biotechnol. 2011, 22(6), 877–881. DOI: https://doi.org/10.1016/j.copbio.2011.06.009.
- Oliveira, S.; Heukers, R.; Sornkom, J.; Kok, R. J.; Van Bergen En Henegouwen, P. M. P. Targeting Tumors with Nanobodies for Cancer Imaging and Therapy. J. Control. Release. 2013, 172(3), 607–617. DOI: https://doi.org/10.1016/j.jconrel.2013.08.298.
- Arranja, A. G.; Pathak, V.; Lammers, T.; Shi, Y. Tumor-Targeted Nanomedicines for Cancer Theranostics. Pharmacol. Res. 2017, 115, 87–95. DOI: https://doi.org/10.1016/j.phrs.2016.11.014.
- Steeland, S.; Vandenbroucke, R. E.; Libert, C. Nanobodies as Therapeutics: Big Opportunities for Small Antibodies. Drug Discov. Today. 2016, 21(7), 1076–1113. DOI: https://doi.org/10.1016/j.drudis.2016.04.003.
- Parveen, S.; Sahoo, S. K. Polymeric Nanoparticles for Cancer Therapy. J. Drug Target. 2008, 16(2), 108–123. DOI: https://doi.org/10.1080/10611860701794353.
- Hamoudeh, M.; Kamleh, M. A.; Diab, R.; Fessi, H. Radionuclides Delivery Systems for Nuclear Imaging and Radiotherapy of Cancer. Adv. Drug Deliv. Rev. 2008, 60(12), 1329–1346. DOI: https://doi.org/10.1016/j.addr.2008.04.013.
- Lammers, T.; Subr, V.; Ulbrich, K.; Hennink, W. E.; Storm, G.; Kiessling, F. Polymeric Nanomedicines for Image-Guided Drug Delivery and Tumor-Targeted Combination Therapy. Nano Today. 2010, 5(3), 197–212. DOI: https://doi.org/10.1016/j.nantod.2010.05.001.
- Sajid, M. I.; Jamshaid, U.; Jamshaid, T.; Zafar, N.; Fessi, H.; Elaissari, A. Carbon Nanotubes from Synthesis to in Vivo Biomedical Applications. Int. J. Pharm. 2016, 501(1–2), 278–299. DOI: https://doi.org/10.1016/j.ijpharm.2016.01.064.
- Tang, Z.; He, C.; Tian, H.; Ding, J.; Hsiao, B. S.; Chu, B.; Chen, X. Polymeric Nanostructured Materials for Biomedical Applications. Prog. Polym. Sci. 2016, 60, 86–128. DOI: https://doi.org/10.1016/j.progpolymsci.2016.05.005.
- Ward, B. B.;. Targeted Therapy in Head and Neck Cancer. Oral Maxillofac. Surg. Clin. North Am. 2013, 25(1), 83–92. DOI: https://doi.org/10.1016/j.coms.2012.11.006.
- Thorp-Greenwood, F. L.; Coogan, M. P. Multimodal Radio- (PET/SPECT) and Fluorescence Imaging Agents Based on Metallo-Radioisotopes: Current Applications and Prospects for Development of New Agents. J. Chem. Soc. Dalton Trans. 2011, 40(23), 6129–6143. DOI: https://doi.org/10.1039/c0dt01398f.
- Fan, A. P.; Jahanian, H.; Holdsworth, S. J.; Zaharchuk, G. Comparison of Cerebral Blood Flow Measurement with [15o]-water Positron Emission Tomography and Arterial Spin Labeling Magnetic Resonance Imaging: A Systematic Review. . J. Cereb. Blood Flow Metab. 2016, 36(5), 842–861. DOI: https://doi.org/10.1177/0271678X16636393.
- de Langen, A. J.; van den Boogaart, V. E. M.; Marcus, J. T.; Lubberink, M. Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow. Oncologist. 2008, 13(6), 631–644. DOI: https://doi.org/10.1634/theoncologist.2007-0235.
- Grüner, J. M.; Paamand, R.; Højgaard, L.; Law, I. Brain Perfusion CT Compared with 15O-H2O-PET in Healthy Subjects. EJNMMI Res. 2011, 1(1), 28. DOI: https://doi.org/10.1186/2191-219X-1-28.
- Boscutti, G.; Huiban, M.; Passchier, J. Use of Carbon-11 Labelled Tool Compounds in Support of Drug Development. Drug Discov. Today Technol. 2017, 25(xx), 3–10. DOI: https://doi.org/10.1016/j.ddtec.2017.11.009.
- Schwaiger, M.;. Myocardial Perfusion Imaging with PET. J. Nucl. Med. 1994, 35, 693–698.
- Cutler, C. S.; Hennkens, H. M.; Sisay, N.; Huclier-Markai, S.; Jurisson, S. S. Radiometals for Combined Imaging and Therapy. Chem. Rev. 2013, 113(2), 858–883. DOI: https://doi.org/10.1021/cr3003104.
- Eckelman, W.;. Review of New Clinical Applications of Radiometal Labeled Radiopharmaceuticals. Nucl. Med. Biol. 2011, 38(5), 613–616. DOI: https://doi.org/10.1016/j.nucmedbio.2010.12.009.
- Rey, A. M.; Radiometal Complexes in Molecular Imaging and Therapy. 2010, 3673–3683.
- Price, E. W.; Orvig, C. Matching Chelators to Radiometals for Radiopharmaceuticals. Chem. Soc. Rev. 2014, 43(1), 260–290. DOI: https://doi.org/10.1039/c3cs60304k.
- Amoroso, A. J.; Fallis, I. A.; Pope, S. J. A. Chelating Agents for Radiolanthanides: Applications to Imaging and Therapy. Coord. Chem. Rev. 2017, 140, 198–219. DOI: https://doi.org/10.1016/j.ccr.2017.01.010.
- Liu, S.;. Bifunctional Coupling Agents for Radiolabeling of Biomolecules and Target-Specific Delivery of Metallic Radionuclides. Adv. Drug Delivery Rev. 2008, 60(12), 1347–1370. DOI: https://doi.org/10.1016/j.addr.2008.04.006.
- Rösch, F.; Herzog, H.; Qaim, S. M. The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y. Pharmaceuticals. 2017, 10(2), 1–28. DOI: https://doi.org/10.3390/ph10020056.
- Qaim, S. M.; Scholten, B.; Neumaier, B. New Developments in the Production of Theranostic Pairs of Radionuclides. J. Radioanal. Nucl. Chem. 2018, 318(3), 1493–1509. DOI: https://doi.org/10.1007/s10967-018-6238-x.
- Qaim, S. M.;. Nuclear Data for Production and Medical Application of Radionuclides: Present Status and Future Needs. Nucl. Med. Biol. 2016. DOI: https://doi.org/10.1016/j.nucmedbio.2016.08.016.
- Rosch, F.; Baum, R. P. Generator-Based PET Radiopharmaceuticals for Molecular Imaging of Tumors: On the Way to THERANOSTICS. Dalton Trans. 2011, 40, 6104–6111. DOI: https://doi.org/10.1039/c0dt01398f.
- Mirzadeh, S.;. Generator-Produced Alpha-Emitters. Appl. Radiat. Isot. 1998, 49(4), 345–349. DOI: https://doi.org/10.1016/S0969-8043(97)00175-9.
- Lambrecht, R. M.; Tomiyoshi, K.; Sekine, T. Radionuclide Generators. Radiochim. Acta. 1997, 77, 103–123.
- Production of Long Lived Parent Radionuclides for Generators : 68Ge, 82Sr, 90Sr, and 188W; IAEA Radioisotopes and Radiopharmaceuticals series publications: Vienna, 2010.
- Ramamoorthy, N.; Goswami, A.; Venugopal, V. Production and Availability of 99mTc Generators and of 99Mo: Technology Considerations and the IAEA’s Contributions; 2007; Vol. 39.
- Le, V. S.;. 99mTc Generator Development: Up-to-Date 99mTc-Recovery Technologies for Increasing the Effectiveness of 99Mo Utilization. Sci. Technol. Nucl. Install. 2014, 2014, 1–41.
- Molinski, V. J. A.;. Review of 99mTc Generator Technology. Int. J. Appl. Radiat. Isot. 1982, 33(10), 811–819. DOI: https://doi.org/10.1016/0020-708X(82)90122-3.
- Vucina, J.; Lukic, D. Radionuclidic Generators for the Production of Technetium-99m and Rhenium-188. Facta Univ. - Ser. Physics, Chem. Technol. 2002, 2(4), 235–243. DOI: https://doi.org/10.2298/FUPCT0204235V.
- Rösch, F.;. Past, Present and Future of 68Ge/68Ga Generators. Appl. Radiat. Isot. 2013, 76, 24–30. DOI: https://doi.org/10.1016/j.apradiso.2012.10.012.
- Braccini, S.;. Compact Medical Cyclotrons and Their Use for Radioisotope Production and Multi-Disciplinary Research. In Proceedings of the 21st International Conference on Cyclotrons and their Applications; 2016; Vol. TUD01, pp 229–234, Zurich, Switzerland, September 11–16.
- Synowiecki, M. A.; Perk, L. R.; Nijsen, J. F. W. Production of Novel Diagnostic Radionuclides in Small Medical Cyclotrons. EJNMMI Radiopharm. Chem. 2018, 3(1), 3. DOI: https://doi.org/10.1186/s41181-018-0038-z.
- Ruth, T.; Wolf, A. P. Absolute Cross Sections for Production of 18F via the 18O (P, N) 18F Reaction. Radiochim. Acta. 1979, 26, 21–24.
- Kambali, I.; Suryanto, H.; Parwanto, P.; Rajiman, R.; Marlina, M. Production of F-18 and Tc-99M Radionuclides Using an 11-Mev Proton-Accelerating Cyclotron. In Proceedings of the 21st International Conference on Cyclotrons and their Applications; 2016; Vol. MOP13; pp 83–86, Zurich, Switzerland, September 11–16.
- Sheu, R. J.; Jiang, S. H.; Duh, T. S. Evaluation of Thallium-201 Production in INER’s Compact Cyclotron Based on Excitation Functions. Radiat. Phys. Chem. 2003, 68(5), 681–688. DOI: https://doi.org/10.1016/S0969-806X(03)00449-3.
- Lebowitz, E.; Greene, M.; Fairchild, R.; Bradley-Moore, P.; Atkins, H.; Ansari, A.; Richards, P.; Belgrave, E. Thallium-201 for Medical Use. J. Nucl. Med. 1974, 16(2), 151–156.
- Bonardi, M.; Birattari, C.; Salomone, A. 201-Tl Production for Medical Use by (P,xn) Nuclear Reactions on Tl and Hg Natural and Enriched Targets. In Proceedings of the International Conference: Nuclear Data For Science and Technology 1983; pp 916–918, Antwerp, Belgium, September 6–10.
- Garcia, F. H.; Andreoiu, C.; Kunz, P. Calculation of In-Target Production Rates for Isotope Beam Production at TRIUMF. Nucl. Instruments Methods Phys. Res. Sect. B Beam Interact. Mater. Atoms. 2017, 412(April), 174–179. DOI: https://doi.org/10.1016/j.nimb.2017.09.023.
- Titarenko, Y. E.;. Experimental and Theoretical Study of the Yields of Residual Product Nuclei Produced in Thin Targets Irradiated by 100-2600 MeV Protons; International Atomic Energy Agency: Vienna, 2003.
- Tung, D.; Lebedev, N.; May, N.; Chang, N.; Halkin, V. Concentration and Isolation of Microamounts of Rare Earth Elements Using Insoluble Collectors (In Russian). Radiochemistry. 1984, 2, 210–214.
- Dash, A.; Pillai, M. R. A.; Knapp, F. F. Production of 177Lu for Targeted Radionuclide Therapy: Available Options. Nuclear Medicine and Molecular Imaging. 2015, pp 85–107. DOI:https://doi.org/10.1007/s13139-014-0315-z.
- Nir-El, Y.;. Production of 177Lu by Neutron Activation of 176Lu. J. Radioanal. Nucl. Chem. 2004, 262(3), 563–567.
- Medical Isotope Production without Highly Enriched Uranium; National Academies Press (US): Washington (DC), 2009.
- Non-HEU Production Technologies for Molybdenum-99 and Technetium-99m; IAEA Nuclear energy series, 2013.
- Zhuikov, B. L.;. Production of Medical Radionuclides in Russia: Status and Future - a Review. Appl. Radiat. Isot. 2014, 84, 48–56. DOI: https://doi.org/10.1016/j.apradiso.2013.11.025.
- Zeituni, C. A.; Rostelato, M. E. C. M.; Jae-son, K.; Lee, J. S.; Costa, O. L.; Moura, J. A.; Feher, A.; Moura, E. S.; Souza, C. D.; Mattos, F. R., Jr, Production of Iodine-125 in Nuclear Reactors: Advantages and Disadvantages of Production in Batch or Continuous Production in Cryogenic System. In International conference on development and applications of nuclear technologies; 2011; pp149–150, Krakow, Poland, September 11–14.
- Ho, H. Q.; Honda, Y.; Hamamoto, S.; Ishii, T.; Fujimoto, N.; Ishitsuka, E. Feasibility Study of Large-Scale Production of Iodine-125 at the High Temperature Engineering Test Reactor. Appl. Radiat. Isot. 2018, 140, 209–214. DOI: https://doi.org/10.1016/j.apradiso.2018.07.024.
- IAEA. Manual for Reactor Produced Radioisotopes; 2003.
- Lebedev, N. A.; Novgorodov, A. F.; Misiak, R.; Brockmann, È.; Ro, F. Radiochemical Separation of No-Carrier-Added 177Lu as Produced via the 176Yb(n, g)177Yb → 177Lu Process. Appl. Radiat. Isot. 2000, 53(3), 421–425.
- Horwitz, E. P.; Mcalister, D. R.; Bond, A. H.; Barrans, R. E.; Williamson, J. M. A Process for the Separation of 177Lu from Neutron Irradiated 176Yb Targets. Appl. Radiat. Isot. 2005, 63(1), 23–36. DOI: https://doi.org/10.1016/j.apradiso.2005.02.005.
- Bilewicz, A.; Barto, B. . Separation of Yb as YbSO4 from the 176Yb Target for Production of 177Lu via the 176Yb (N, γ) 177Yb → 177Lu Process. Journal of Radioanalytical and Nuclear Chemistry. 2009, 280(1), 167–169. DOI: https://doi.org/10.1007/s10967-008-7437-7.
- Division, R.; Atomic, B.; Chakravarty, R.; Das, T.; Dash, A.; Venkatesh, M. An Electro-Amalgamation Approach to Isolate No-Carrier-Added Neutron Irradiated Yb for Biomedical Applications Lu From. Nucl. Med. Biol. 2010, 37(7), 811–820. DOI: https://doi.org/10.1016/j.nucmedbio.2010.04.082.
- Barkhausen, C.; Zhernosekov, K. Production of n.c.a. 177Lu at FRM II for radiopharmaceutical applications.
- Lehenberger, S.; Barkhausen, C.; Cohrs, S.; Fischer, E.; Grünberg, J.; Hohn, A.; Köster, U.; Schibli, R.; Türler, A.; Zhernosekov, K. The Low-Energy β − and Electron Emitter 161Tb as an Alternative to Lu for Targeted Radionuclide Therapy. Nucl. Med. Biol. 2011, 38(6), 917–924. DOI: https://doi.org/10.1016/j.nucmedbio.2011.02.007.
- Knapp, F. F.; Mirzadeh, S.; Beets, A. L.; Du, M. Production Of Therapeutic Radioisotopes In The Ornl High Flux Isotope Reactor (HFIR) for Applications in Nuclear Medicine, Oncol. Interventional Cardiol. 2008, 263(2), 503–509.
- Saied, B. M.; Naji, N. F.; Abd al-Ameer, A. L. M. Yields for the Production of Phosphorus-32 Using the Charged and Uncharged Particles in Medical Practice. Int. J. Med. Pharma. Sci. 2015, 5(1), 67–76.
- Alanís, J.; Navarrete, M. Industrial Production and Purification of 32P by Sulfur Irradiation with Partially Moderated Neutron Fluxes and Target Melting. J. Radioanal. Nucl. Chem. 2007, 273(3), 659–662. DOI: https://doi.org/10.1007/s10967-007-0927-1.
- Vimalnath, K. V.; Shetty, P.; Chakraborty, S.; Das, T.; Chirayil, V.; Sarma, H. D.; Jagadeesan, K. C.; Joshi, P. V. Practicality of Production of 32P by Direct Neutron Activation for Its Utilization in Bone Pain Palliation as Na3[32P]PO4. Cancer Biother. Radiopharm. 2013, 28(5), 423–428. DOI: https://doi.org/10.1089/cbr.2012.1335.
- Lewis, R. E.; Butler, T. A. Production of 33P from 36Cl and 33S by Fast-Neutron Irradiation. Nucl. Appl. 1966, 2(2), 102–105. DOI: https://doi.org/10.13182/NT66-A27488.
- Westermark, T.;. Production of 33P with Thermal Neutrons. Phys. Rev. 1952, 88(3), 573–574.
- Viennot, M.; Berrada, M.; Paic, G.; Joly, S. Cross-Section Measurements of (N,p) and (N,np + Pn + D) Reactions for Some Titanium, Chromium, Iron, Cobalt, Nickel, and Zinc Isotopes around 14 MeV. Nucl. Sci. Eng. 1991, 108(3), 289–301. DOI: https://doi.org/10.13182/NSE87-157.
- Broeders, C. H. M.; Konobeyev, A. Y. Semi-Empirical Systematics of (N, P) Reaction Cross-Section at 14.5, 20, and 30 MeV. Nucl. Phys. A. 2006, 780(3–4), 130–145. DOI: https://doi.org/10.1016/j.nuclphysa.2006.09.015.
- AGENCY, N. E. The Supply of Medical Radioisotopes: Review of Potential Molybdenum-99/Technetium-99m Production Technologies. Nea-Oecd 2010, November.
- IAEA. Handbook on Photonuclear Data for Applications Cross-Sections and Spectra; International Atomic Energy Agency: Vienna, 2000.
- Roesch, F.; Knapp, F. F. Radionuclide Generators. In Handbook of Nuclear Chemistry; 2011; pp 1936–1976. DOI:https://doi.org/10.1007/978-1-4419-0720-2
- Yano, Y.; Chu, P.; Budinger, T. F.; Grant, P. M.; Ogard, A. E.; Barnes, J. W.; O’Brien, H. A.; Hoop, B. Rubidium-82 Generators for Imaging Studies. J. Nucl. Med. 1977, 18(1), 46–50. DOI: https://doi.org/10.1007/s12665-009-0321-0.
- Sylvester, P.; Möller, T.; Adams, T. W.; Cisar, A. New Ion Exchange Materials for Use in a 82Sr/82Rb Generator. Appl. Radiat. Isot. 2004, 61(6), 1139–1145. DOI: https://doi.org/10.1016/j.apradiso.2004.02.029.
- Chinol, M.; Hnatowich, D. J. Generator-Produced Yttrium-90 for Radioimmunotherapy. J. Nucl. Med. 1987, 28(9), 1465–1470.
- Guseva, L. I.; Dogadkin, N. N. Development of a Tandem Generator System 229Th/225Ac/213Bi for Repeated Production of Short-Lived α-Emitting Radionuclides. Radiochemistry. 2009, 51(2), 169–174. DOI: https://doi.org/10.1134/S1066362209020131.
- Guseva, L. I.;. A Tandem Generator System for Production of 223Ra and 211Pb/211Bi in DTPA Solutions Suitable for Potential Application in Radiotherapy. J. Radioanal. Nucl. Chem. 2009, 281(3), 577–583. DOI: https://doi.org/10.1007/s10967-009-0044-4.
- Knapp, F. F.; Beets, A. L.; Mirzadeh, S.; Guhlke, S. Use of a New Tandem Cation/Anion Exchange System with Clinical-Scale Generators Provides High Specific Volume Solutions of Technetium-99m and Rhenium-188. In Proceedings of Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy, 1998; pp 419–425, Lisbon, Portugal, March 30–April 3.
- Johnson, K.; Mcglynn, B.; Saggio, J.; Baniewicz, D.; Zhuang, H.; Maris, J. M.; Mosse, Y. P. Safety and Efficacy of Tandem 131I-Metaiodobenzylguanidine Infusions in Relapsed/Refractory Neuroblastoma. Pediatr. Blood Cancer. 2011, 57, 1124–1129. DOI: https://doi.org/10.1002/pbc.
- Dadakhanov, J. A.; Lebedev, N. A.; Velichkov, A. I.; Karaivanov, D. V.; Baimukhanova, A. E.; Temerbulatova, N. T.; Filosofov, D. V. 172Hf → 172Lu Radionuclide Generator Based on a Reverse-Tandem Separation Scheme. Radiochemistry. 2018, 60(4), 415–426. DOI: https://doi.org/10.1134/S1066362218040112.
- Filosofov, D. V.; Loktionova, N. S.; Rösch, F. A 44Ti/44Sc Radionuclide Generator for Potential Application of 44Sc-Based PET-Radiopharmaceuticals. Radiochim. Acta. 2010, 98(3), 149–156. DOI: https://doi.org/10.1524/ract.2010.1701.
- Zielinska, B.; Apostolidis, C.; Bruchertseifer, F.; Morgenstern, A. An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy. Solvent Extr. Ion Exch. 2007, 25(3), 339–349. DOI: https://doi.org/10.1080/07366290701285108.
- Morgenstern, A.;. Bismuth-213 and Actinium-225–Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes. Curr. Radiopharm. 2012, 5(3), 221–227. DOI: https://doi.org/10.2174/1874471011205030221.
- Wu, C.; Brechbiel, M. W.; Gansow, O. A. An Improved Generator for the Production of 213Bi from 225Ac. Radiochim. Acta. 1997, 79(2), 141–144.
- Mcdevitt, M. R.; Finn, R. D.; Sgouros, G.; Ma, D.; Scheinberg, D. A. An 225Ac/213Bi Generator System for Therapeutic Clinical Applications: Construction and Operation. Appl. Radiat. Isot. 1999, 50, 895–904.
- Ma, D.; McDevitt, M. R.; Finn, R. D.; Scheinberg, D. A. Breakthrough of 225Ac and Its Radionuclide Daughters from an 225Ac/213Bi Generator: Development of New Methods, Quantitative Characterization, and Implications for Clinical Use. Appl. Radiat. Isot. 2001, 55(5), 667–678. DOI: https://doi.org/10.1016/S0969-8043(01)00062-8.
- Boll, R. A.; Mirzadeh, S.; Kennel, S. J. Optimizations of Radiolabeling of Immunoproteins with 213Bi. Radiochim. Acta. 1997, 79(2), 145–149.
- Waste Treatment and Technologies Involving Inorganic Sorbents; Waste technology section IAEA, 1997.
- Series, I. T. IAEA-TECDOC-1853. 1863.
- Pandey, M. K.; Byrne, J. F.; Jiang, H.; Packard, A. B.; DeGrado, T. R. Cyclotron Production of (68)ga via the (68)zn(p,n)(68)ga Reaction in Aqueous Solution. Am. J. Nucl. Med. Mol. Imaging. 2014, 4(4), 303–310.
- Alves, V.; Do Carmo, S.; Alves, F.; Abrunhosa, A. Automated Purification of Radiometals Produced by Liquid Targets. Instruments. 2018, 2(3), 17. DOI: https://doi.org/10.3390/instruments2030017.
- Pedersen, K. S.; Imbrogno, J.; Fonslet, J.; Marcella Lusardi, K. F.; Jensen, F. Z. Liquid–Liquid Extraction in Flow of the Radioisotope Titanium-45 for Positron Emission Tomography Applications. React. Chem. Eng. 2018, 3, 898–904. DOI: https://doi.org/10.1039/c8re00175h.
- Søborg Pedersen, K.; Baun, C.; Michaelsen Nielsen, K.; Thisgaard, H.; Ingemann Jensen, A. Design, Synthesis, Computational, and Preclinical Evaluation of NatTi/45Ti-Labeled Urea-Based Glutamate PSMA Ligand. Molecules. 2020, 25(5), 1–19.
- Pedersen, K. S.; Nielsen, K. M.; Fonslet, J.; Zhuravlev, F.; Søborg, K.; Nielsen, K. M.; Fonslet, J. Separation of Radiogallium from Zinc Using Membrane-Based Liquid-Liquid Extraction in Flow: Experimental and COSMO-RS Studies Separation of Radiogallium from Zinc Using Membrane-Based Liquid-Liquid Extraction in Flow: Experimental and COSMO-RS. Solvent Extr. Ion Exch. 2019, 37(5), 376–391. DOI: https://doi.org/10.1080/07366299.2019.1646982.
- Kasbollah, A.; Eu, P.; Cowell, S.; Deb, P. Review on Production of 89Zr in a Medical Cyclotron for PET Radiopharmaceuticals. J. Nucl. Med. Technol. 2013, 41, 35–41. DOI: https://doi.org/10.2967/jnmt.112.111377.
- Radchenko, V.; Filosofov, D. V.; Bochko, O. K.; Lebedev, N. A.; Rakhimov, A. V.; Hauser, H.; Eisenhut, M.; Aksenov, N. V.; Bozhikov, G. A.; Ponsard, B.; et al. Separation of 90Nb from Zirconium Target for Application in Immuno-Pet. Radiochim. Acta. 2014, 102(5), 433–442. DOI: https://doi.org/10.1515/ract-2013-2156.
- Alliot, C.; Kerdjoudj, R.; Michel, N.; Haddad, F.; Huclier-markai, S. Cyclotron Production of High Purity 44m,44Sc with Deuterons from 44CaCO3 Targets. Nucl. Med. Biol. 2015, 42(6), 524–529. DOI: https://doi.org/10.1016/j.nucmedbio.2015.03.002.
- Radchenko, V.; Engle, J. W.; Wilson, J. J.; Maassen, J. R.; Nortier, F. M.; Taylor, W. A.; Birnbaum, E. R.; Hudston, L. A.; John, K. D.; Fassbender, M. E. Application of Ion Exchange and Extraction Chromatography to the Separation of Actinium from Proton-Irradiated Thorium Metal for Analytical Purposes. J. Chromatogr. A. 2015, 1380, 55–63. DOI: https://doi.org/10.1016/j.chroma.2014.12.045.
- Radchenko, V.; Meyer, C. A. L.; Engle, J. W.; Naranjo, C. M.; Unc, G. A.; Mastren, T.; Brugh, M.; Birnbaum, E. R.; John, K. D.; Nortier, F. M.; et al. Separation of 44Ti from Proton Irradiated Scandium by Using Solid-Phase Extraction Chromatography and Design of 44Ti/44Sc Generator System. J. Chromatogr. A. 2016, 1477, 39–46. DOI: https://doi.org/10.1016/j.chroma.2016.11.047.
- Radchenko, V.; Mastren, T.; Meyer, C. A. L.; Ivanov, A. S.; Bryantsev, V. S.; Copping, R.; Denton, D.; Engle, J. W.; Griswold, J. R.; Murphy, K.; et al. Radiometric Evaluation of Diglycolamide Resins for the Chromatographic Separation of Actinium from Fission Product Lanthanides. Talanta. 2017, 175(June), 318–324. DOI: https://doi.org/10.1016/j.talanta.2017.07.057.
- Ramogida, C. F.; Orvig, C. Tumour Targeting with Radiometals for Diagnosis and Therapy. Chem. Commun. 2013, 49, 4720–4739. DOI: https://doi.org/10.1039/c3cc41554f.
- Tircso, G.; Kovacs, Z.; Sherry, A. D. Equilibrium and Formation/Dissociation Kinetics of Some LnIIIPCTA Complexes. Inorg. Chem. 2006, 45(23), 9269–9280.
- Byeg, J.; Skarnemark, G.; Skhlberg, M. The Stability of Some Metal EDTA, DTPA and DOTA Complexes: Application as Tracers in Groundwater Studies. J. Radioanal. Nucl. Chem. 1999, 241(2), 281–290.
- Hyvönen, H.; Studies on Metal Complex Formation of Environmentally Friendly Aminopolycarboxylate Chelating Agents; PhD thesis, 2008.
- Zhernosekov, K. P.; Filosofov, D.; Baum, V.; Aschoff, R. P.; Bihl, P.; Razbash, H.; Jahn, A. A.; Jennewein, M.; Rösch, M. Processing of Generator-Produced 68Ga for Medical Application. J. Nucl. Med. 1741–1748, 2007(48). DOI: https://doi.org/10.2967/jnumed.107.040378.
- Kubicek, V.; Havlickova, J.; Koek, J.; Tircs, G.; Hermann, P.; Toth, E.; Lukes, I. Gallium(III) Complexes of DOTA and DOTA - Monoamide: Kinetic and Thermodynamic Studies. Inorg. Chem. 2010, 49, 10960–10969. DOI: https://doi.org/10.1021/ic101378s.
- Pasha, A.; Tircso, G.; Benyo, E. T.; Brucher, E.; Sherry, A. D. Synthesis and Characterization of DOTA-(Amide)4 Derivatives: Equilibrium and Kinetic Behavior of Their Lanthanide(III) Complexes. Eur. J. Inorg. Chem. 2007, 27, 4340–4349. DOI: https://doi.org/10.1002/ejic.200700354.
- Pérez-Malo, M.; Szabó, G.; Eppard, E.; Vagner, A.; Brücher, E.; Tóth, I.; Maiocchi, A.; Suh, E. H.; Kovács, Z.; Baranyai, Z.; et al. Improved Efficacy of Synthesizing *miii-labeled DOTA Complexes in Binary Mixtures of Water and Organic Solvents. A Combined Radio- and Physicochemical Study. Inorg. Chem. 2018, 57(10), 6107–6117. DOI: https://doi.org/10.1021/acs.inorgchem.8b00669.